Skip to main content

Inside Ginkgo Bioworks' efforts to dramatically scale Covid-19 testing

For Jason Kelly, co-founder and CEO of the 12-year-old biotech, the most powerful tool in his toolbox to fight the Covid-19 pandemic is simple: testing as many people as possible, as often as possible.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.